A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study to Evaluate the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Ulcerative Colitis

  • Leong, Rupert (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Parshionikar, Abhijit (Clinical Trial Unit Staff)
  • Rajasekharan Nair, Archana (Clinical Trial Unit Staff)

Project: Other

Project Details

Effective start/end date17/12/1924/09/24